The Q4 data highlights sustained growth in key specialty sectors, marked by notable increases in SP drug approvals and ...

Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...

Tocilizumab biosimilar is under clinical development by Celltrion and currently in Pre-Registration for Rheumatoid Arthritis. According to GlobalData, Pre-Registration drugs for Rheumatoid Arthritis ...

Other solutions to help lower prescription drug costs include reference pricing, biosimilar substitution and importation. Housing policies should include a focus on: Affordability and a range of ...

We are aware of reports regarding supply issues of insulin in the UK. Here’s the latest information on how your treatment may be impacted.

WASHINGTON, Dec. 17, 2024 /PRNewswire/ -- Biosimilars could lower the cost of treating cancer, autoimmune disorders and other serious conditions if policies allowed patients to access the medicati ...

This near miss is a common incident in the community practice setting given its fast pace and evolving prevalence of biosimilar usage. Biosimilars May Decrease The Cost Of Cancer Care The trajectory ...

The Phase III win could help Regeneron and Bayer expand into retinal vein occlusion, a move that the partners need to help shore up sales of their Eylea franchise amid biosimilar encroachment. The ...

The findings suggest… Tyruko (natalizumab), the first biosimilar of Tysabri, is now available in Germany for adults with highly active relapsing-remitting multiple sclerosis (RRMS).

Biocon Ltd’s biosimilars subsidiary Biocon Biologics Ltd (BBL), just received approval from the US Food and Drug Administration (FDA) for its drug YESINTEK, a biosimilar to another product ...

Your browser does not support the video tag. Changing your app icons on Android is easy, but it is also a non-intuitive process. But if you wish to maximize your ...